What is the address of Vistacare Med?

The registered office of Vistacare Med is located at Tentoonstellingslaan 408 box 57, 1090 Jette.

Is Vistacare Med still active?

Yes. According to the CBE (29 October 2026) Vistacare Med is active, legal situation “Normale toestand”, started on 8 June 2018.

Is Vistacare Med registered on Peppol?

No, Vistacare Med is currently not registered on the Peppol network.

What is the enterprise number of Vistacare Med?

The enterprise number of Vistacare Med is BE0697773062.

When was Vistacare Med founded?

Vistacare Med was founded on 8 June 2018.

Who are the directors of Vistacare Med?

According to the 2025 annual accounts, the directors of Vistacare Med are: Jaydeep Shekhda, Elena-Raluca Dragan.

Is Vistacare Med a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 June 2018; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Vistacare Med make in 2025?

Vistacare Med posted a profit after taxes of € 9,611 in financial year 2025.

What is the revenue of Vistacare Med?

As a small company, Vistacare Med is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 14,430.

Vistacare Med (Private Limited) - Jette - BE0697773062

Dossier Vistacare Med, printed on 29 October 2026 from databakkes.be/en/0697773062/vistacare-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Vistacare Med from Jette, company number BE0697773062, closed financial year 2025 with a result of € 9,611 after tax. For that financial year Vistacare Med recorded a gross margin of € 14,430 and equity of € 12,858. Compared with financial year 2024, the result moved from € 23,528 to € 9,611. The company is profitable. The buffer shrank hard: equity is 69 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 7, 2026.

What it is worth Shrank hard

€ 12,858

▼ 69% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 9,611

▼ 59% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 48,214

▼ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 38,080 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 1,012

▼ 34% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 231

▼ 76% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,712

▼ 42% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 10,066 Gross margin 2022: € 10,066 First fiscal year in the series	€ 18,759 Gross margin 2023: € 18,759 ▲ 86% vs 2022 (€ 10,066) Favourable step	€ 34,110 Gross margin 2024: € 34,110 ▲ 82% vs 2023 (€ 18,759) Favourable step	€ 14,430 Gross margin 2025: € 14,430 ▼ 58% vs 2024 (€ 34,110) Unfavourable step	▼ 58%
Profit after taxes	€ 1,736 Profit after taxes 2022: € 1,736 First fiscal year in the series	€ 15,548 Profit after taxes 2023: € 15,548 ▲ € 13,812 vs 2022 (€ 1,736) Favourable step	€ 23,528 Profit after taxes 2024: € 23,528 ▲ 51% vs 2023 (€ 15,548) Favourable step	€ 9,611 Profit after taxes 2025: € 9,611 ▼ 59% vs 2024 (€ 23,528) Unfavourable step	▼ 59%
Equity	€ 2,251 Equity 2022: € 2,251 First fiscal year in the series	€ 17,799 Equity 2023: € 17,799 ▲ € 15,548 vs 2022 (€ 2,251) Favourable step	€ 41,327 Equity 2024: € 41,327 ▲ 132% vs 2023 (€ 17,799) Favourable step	€ 12,858 Equity 2025: € 12,858 ▼ 69% vs 2024 (€ 41,327) Unfavourable step	▼ 69%
Total debts	€ 19,542 Total debts 2022: € 19,542 First fiscal year in the series	€ 18,454 Total debts 2023: € 18,454 ▼ 6% vs 2022 (€ 19,542) Favourable step	€ 31,232 Total debts 2024: € 31,232 ▲ 69% vs 2023 (€ 18,454) Unfavourable step	€ 42,676 Total debts 2025: € 42,676 ▲ 37% vs 2024 (€ 31,232) Unfavourable step	▲ 37%
Cash	€ 21,393 Cash 2022: € 21,393 First fiscal year in the series	€ 35,829 Cash 2023: € 35,829 ▲ 67% vs 2022 (€ 21,393) Favourable step	€ 71,015 Cash 2024: € 71,015 ▲ 98% vs 2023 (€ 35,829) Favourable step	€ 48,214 Cash 2025: € 48,214 ▼ 32% vs 2024 (€ 71,015) Unfavourable step	▼ 32%
Retained profit	€ -10,149 Retained profit 2022: € -10,149 First fiscal year in the series	€ 5,399 Retained profit 2023: € 5,399 ▲ € 15,548 vs 2022 (€ -10,149) Favourable step	€ 28,927 Retained profit 2024: € 28,927 ▲ € 23,528 vs 2023 (€ 5,399) Favourable step	€ 458 Retained profit 2025: € 458 ▼ 98% vs 2024 (€ 28,927) Unfavourable step	▼ 98%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 38,080 Dividend 2025: € 38,080 Unchanged (€ 0) Unchanged
Bank debt	€ 6,436 Bank debt 2022: € 6,436 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 6,436) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 21,793 Balance sheet total 2022: € 21,793 First fiscal year in the series	€ 36,253 Balance sheet total 2023: € 36,253 ▲ 66% vs 2022 (€ 21,793) Unchanged	€ 72,560 Balance sheet total 2024: € 72,560 ▲ 100% vs 2023 (€ 36,253) Unchanged	€ 55,534 Balance sheet total 2025: € 55,534 ▼ 23% vs 2024 (€ 72,560) Unchanged	▼ 23%

Key figures of Vistacare Med, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Vistacare Med?

What happened at Vistacare Med in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 7, 2026 New annual accounts for financial year 2025: profit of € 9,611 (▼ 59% vs 2024). filed late Source: NBB ↗
Jun 8, 2018 New establishment in Jette. KBO
Jun 8, 2018 Start of the company according to the CBE. KBO

In short

From € 1,736 profit in 2022 to € 9,611 profit in 2025.

Paid € 16,235 in corporate taxes since 2022.

Best year ever: 2024, with € 23,528 profit.

Paid out € 38,080 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Jaydeep Shekhda Elena-Raluca Dragan

Vistacare Med

Behind Vistacare Med are Jaydeep Shekhda and Elena-Raluca Dragan.

Directors

According to the 2025 annual accounts

Jaydeep Shekhda

Manager

Elena-Raluca Dragan

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Tentoonstellingslaan 408 box 57

1090 Jette

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

ZHILIAN

€ 179,939 gross margin · 2025

LHCH INTERNATIONAL

€ -903 gross margin · 2025

A.C.P. AV EXPOSITION 408

Mugisha Entertainment

Europe-Afrique-Asie Industrie et Investissement Alliance

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0697.773.062
VAT number: BE 0697.773.062
Registered office: Tentoonstellingslaan 408 bus 57, 1090 Jette
Names & denominations: Vistacare Med
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 June 2018
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗